| Literature DB >> 26887639 |
Liina Voutilainen1,2, Eva R Kallio3, Jukka Niemimaa1, Olli Vapalahti2,4, Heikki Henttonen1.
Abstract
Understanding the dynamics of zoonotic pathogens in their reservoir host populations is a prerequisite for predicting and preventing human disease epidemics. The human infection risk of Puumala hantavirus (PUUV) is highest in northern Europe, where populations of the rodent host (bank vole, Myodes glareolus) undergo cyclic fluctuations. We conducted a 7-year capture-mark-recapture study to monitor seasonal and multiannual patterns of the PUUV infection rate in bank vole populations exhibiting a 3-year density cycle. Infected bank voles were most abundant in mid-winter months during years of increasing or peak host density. Prevalence of PUUV infection in bank voles exhibited a regular, seasonal pattern reflecting the annual population turnover and accumulation of infections within each year cohort. In autumn, the PUUV transmission rate tracked increasing host abundance, suggesting a density-dependent transmission. However, prevalence of PUUV infection was similar during the increase and peak years of the density cycle despite a twofold difference in host density. This may result from the high proportion of individuals carrying maternal antibodies constraining transmission during the cycle peak years. Our exceptionally intensive and long-term dataset provides a solid basis on which to develop models to predict the dynamic public health threat posed by PUUV in northern Europe.Entities:
Mesh:
Year: 2016 PMID: 26887639 PMCID: PMC4758042 DOI: 10.1038/srep21323
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
The known (uppercase) and assigned (lowercase) PUUV status of all bank vole captures on the core grid.
| PUUV antibody/infection status | Number |
|---|---|
| Seronegative; susceptible at | 1871 |
| 78 | |
| 97 | |
| 669 | |
| 114.0 | |
| Seropositive (P): infected (I/i) or protected by maternal antibodies (M/m) at | 1415 |
| 828 | |
| 364 | |
| 47 | |
| 31 | |
| 52 | |
| 49.6 | |
| 184.4 | |
| 118.2 | |
| 7 | |
| Total PUUV infection status | |
| | 1871.0 |
| | 1235.4 |
| | 179.6 |
| Total N of captures | 3286 |
P = seropositive, S/s = susceptible, M/m = maternal antibody positive, I/i = infected, 0 = not in population, ? = unknown, x = undetermined.
Capital letters indicate status deduced from serological history, small letters the assigned status.
In PUUV infection/antibody status, the first character indicates PUUV status at t−1 (previous trapping session), and second character the PUUV status at t (current trapping session).
Seroconversion rates for total population and yearly cohorts per trapping session were calculated from (SI + si)/(SS + SI + ss + si), marked in bold.
AICc (Akaike information criterion adjusted for sample size) scores of all candidate generalized additive models (GAMs).
| Candidate models | Dependent variable | ||
|---|---|---|---|
| Abundance of infected | Infection prevalence | Seroconversion rate | |
| Within-cycle dynamics | |||
| cycle ID + s(cycle month by cycle ID) | 543.3 | ||
| cycle ID + s(cycle month) | 646.9 | 533.2 | 186.0 |
| s(cycle month) | 762.9 | 184.3 | |
| cycle ID | 643.9 | 953.7 | 193.9 |
| intercept only | 761.0 | 951.2 | 196.5 |
| Within-year dynamics | |||
| cycle phase + s(month by cycle phase) | 507.4 | 134.6 | |
| cycle phase + s(month) | 600.1 | 134.1 | |
| s(month) | 610.3 | 497.2 | 136.5 |
| cycle phase | 1374.8 | 549.0 | |
| intercept only | 1381.2 | 550.9 | 135.5 |
| Variation in relation to breeding season (dichotomous) | |||
| cycle phase * breeding season | 130.4 | ||
| cycle phase + breeding season | |||
| breeding season | 130.4 | ||
| cycle phase | 130.8 | ||
| intercept only | 134.1 | ||
| Variation in relation to cohort age and birth year cycle phase | |||
| cycle phase + s(cohort age by cycle phase) | 183.3 | ||
| cycle phase + s(cohort age) | 158.3 | ||
| s(cohort age) | 205.3 | 160.9 | |
| cycle phase | 519.4 | 158.7 | |
| intercept only | 642.2 | 161.9 | |
s(…) denote GAM smooth terms.
The AICc scores of the best-supported models are written in bold.
Figure 1The number of bank voles on the core (lines) and satellite grids (crosses), (a) in total and (b) according to PUUV infection status. Values for the 14 satellite grids are pooled. Shaded areas indicate phases (Jun 1st to May 31st) of increasing (light grey), peak (dark grey) and low (white) vole density. In a, vertical lines indicate trapping sessions on the core grid. In b, colours indicate infection status: susceptible for PUUV infection (blue), infected with PUUV (red), and MatAb+ (green).
Parameter estimates of the best-supported models analysing the within-cycle and within-year dynamics in the abundance of PUUV infected bank voles, infection prevalence and seroconversion rate.
| Dependent variable/source of variation | Within-cycle dynamics | Within-year dynamics | |||||
|---|---|---|---|---|---|---|---|
| Abundance of Infected | |||||||
| | |||||||
| intercept | −4.15 (0.24) | −17.1 | <0.001 | −3.85 (0.15) | −24.9 | <0.001 | |
| cycle ID | 2004–2006 | −0.02 (0.25) | −0.1 | 0.95 | |||
| 2007–2009 | −0.06 (0.71) | −0.1 | 0.938 | ||||
| cycle phase | peak | 0.40 (0.17) | 2.4 | 0.016 | |||
| low | −2.67 (0.36) | −7.5 | <0.001 | ||||
| | |||||||
| cycle month by cycle ID | 2001–2003 | 1 (1) | 55 | <0.001 | |||
| 2004–2006 | 7.08 (7.08) | 190 | <0.001 | ||||
| 2007–2009 | 5.70 (5.70) | 124 | <0.001 | ||||
| month by cycle phase | increase | 2.08 (2.08) | 13.6 | 0.001 | |||
| peak | 2.08 (2.08) | 22.7 | <0.001 | ||||
| low | 1.95 (1.95) | 4.4 | 0.105 | ||||
| | |||||||
| site | within cycle 2001–2003 | 0.64 | 0.80 | ||||
| within cycle 2004–2006 | 0.31 | 0.56 | |||||
| within cycle 2007–2009 | 1.34 | 1.16 | |||||
| observation | 0.70 | 0.84 | |||||
| site | 0.09 | 0.31 | |||||
| Infection prevalence | |||||||
| | |||||||
| intercept | −1.11 (0.15) | −7.3 | <0.001 | −0.85 (0.22) | −3.8 | <0.001 | |
| cycle phase | peak | 0.19 (0.30) | 0.6 | 0.517 | |||
| low | −0.77 (0.36) | −2.1 | 0.032 | ||||
| | |||||||
| cycle month/month | 6.82 (6.82) | 41.7 | <0.001 | 3.07 (3.07) | 31.1 | <0.001 | |
| | |||||||
| site | within cycle 2001–2003 | 0.75 | 0.87 | ||||
| within cycle 2004–2006 | 0.98 | 0.99 | |||||
| within cycle 2007–2009 | 1.42 | 1.19 | |||||
| observation | 0.43 | 0.65 | |||||
| Seroconversion rate | |||||||
| | |||||||
| intercept | −6.06 (1.28) | −4.7 | <0.001 | −5.31 (0.14) | −37.4 | <0.001 | |
| cycle ID | 2004–2006 | 0.20 (1.30) | 0.2 | 0.88 | |||
| 2007–2009 | 1.27 (1.85) | 0.7 | 0.497 | ||||
| cycle phase | peak | −0.27 (0.19) | −1.4 | 0.161 | |||
| low | −2.19 (1.41) | −1.5 | 0.128 | ||||
| | |||||||
| cycle month by cycle ID | 2001–2003 | 1.43 (1.76) | 3.8 | 0.036 | |||
| 2004–2006 | 2.12 (2.71) | 2 | 0.129 | ||||
| 2007–2009 | 4.85 (5.53) | 3.5 | 0.007 | ||||
Edf = Estimated degrees of freedom; rdf = residual degrees of freedom; σ2 = the variance attributable to random effect.
sd = standard deviation of σ2.
Figure 2Variation in the (a,b) abundance of PUUV-infected bank voles/100 trap nights, (c,d) PUUV infection prevalence, and (e,f) seroconversion rate within the time frame of (a,c,e) a vole density cycle and (b,d,f) a year. Lines represent predicted values for the core grid from the best-supported models ((a) cycle ID + s[cycle month by cycle ID]; (b) cycle phase + s[month by cycle phase]; (c) s[cycle month]; (d) cycle phase + s[month]; (e) cycle ID + s[cycle month by cycle ID]; (f) cycle phase; s[…] denote GAM smooth terms). Shaded areas indicate the 95% confidence intervals of parameter estimates. “C” and “S” in a−e denote observed data in core and pooled satellite grids, respectively. Numbers 1−8 in f denote biological years 2001−2008. The character sizes indicate the number of animals (c,d) and total days of exposure (e,f). Green, red, and blue colours indicate different cycles in (a,c,e) and different cycle phases in (b,d,f).
Parameter estimates of the best-supported models analysing the PUUV infection prevalence and seroconversion rate during the lifespan of a yearly bank vole cohort.
| Dependent variable/source of variation | Parameter estimates | |||
|---|---|---|---|---|
| Infection prevalence | ||||
| | ||||
| intercept | −0.16 (0.13) | −1.2 | 0.217 | |
| birth year cycle phase | peak | −0.27 (0.15) | −1.8 | 0.08 |
| low | −3.41 (0.93) | −3.7 | < 0.001 | |
| | ||||
| cohort age | 3.89 (4.83) | 48.5 | <0.001 | |
| Seroconversion rate | ||||
| | ||||
| intercept | −5.53 (0.25) | −22.2 | < 0.001 | |
| birth year cycle phase | peak | −0.11 (0.30) | −0.4 | 0.716 |
| low | −2.12 (1.70) | −1.2 | 0.219 | |
| | ||||
| cohort age by birth year cycle phase | increase | 3.62 (4.49) | 1.8 | 0.125 |
| peak | 1.00 (1.00) | 0.1 | 0.714 | |
| low | 1.00 (1.00) | 0.9 | 0.358 | |
Edf = Estimated degrees of freedom; rdf = Residual degrees of freedom.
Figure 3The (a) prevalence of PUUV infection and (a) seroconversion rate during the lifespan of a yearly bank vole cohort in relation to density cycle phase at birth. Solid lines represent predicted values from the best-supported models ((a) cycle phase + s[cohort age]; (b) cycle phase + s[cohort age by cycle phase]; s[…] denote GAM smooth terms). Shaded areas indicate the 95% confidence intervals of parameter estimates. Dashed lines in a indicate the total number of individuals in yearly cohorts, and colours denote the cycle phase at the summer of birth. Numbers 1−8 denote yearly cohorts 2001 to 2008, their size indicating the total (a) and the number of susceptible (b) animals.